95
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The Additional Prognostic Value of Ghrelin for Mortality and Readmission in Elderly Patients with Acute Heart Failure

, , & ORCID Icon
Pages 1353-1363 | Published online: 11 Aug 2020

References

  • Sawano M, Shiraishi Y, Kohsaka S, et al. Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides. ESC Heart Fail. 2018;5(4):610–619. doi:10.1002/ehf2.1227829520978
  • Demissei BG, Postmus D, Cleland JG, et al. Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure. Eur J Heart Fail. 2017;19(6):728–738. doi:10.1002/ejhf.76628251755
  • Khatib MN, Simkhada P, Gode D. Cardioprotective effects of ghrelin in heart failure: from gut to heart. Heart Views. 2014;15(3):74–76. doi:10.4103/1995-705X.14479225538820
  • Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. doi:10.1002/ejhf.59227207191
  • Mebazaa A, Di Somma S, Maisel AS, Bayes-Genis A. ST2 and multimarker testing in acute decompensated heart failure. Am J Cardiol. 2015;115(7 Suppl):38B–43B. doi:10.1016/j.amjcard.2015.01.039
  • Carrasco-Sanchez FJ, Aramburu-Bodas O, Salamanca-Bautista P, et al. Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction. Int J Cardiol. 2013;169(3):177–182. doi:10.1016/j.ijcard.2013.08.08124207066
  • Zhao J, Zhang C, Liu J, et al. Prognostic significance of serum cysteine-rich protein 61 in patients with acute heart failure. Cell Physiol Biochem. 2018;48(3):1177–1187. doi:10.1159/00049198430045012
  • Tokudome T, Otani K, Miyazato M, Kangawa K. Ghrelin and the heart. Peptides. 2019;111(111):42–46. doi:10.1016/j.peptides.2018.05.00629791869
  • Kishimoto I, Tokudome T, Hosoda H, Miyazato M, Kangawa K. Ghrelin and cardiovascular diseases. J Cardiol. 2012;59(1):8–13. doi:10.1016/j.jjcc.2011.11.00222178336
  • Lilleness BM, Frishman WH. Ghrelin and the cardiovascular system. Cardiol Rev. 2016;24(6):288–297. doi:10.1097/CRD.000000000000011327465535
  • Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110(24):3674–3679. doi:10.1161/01.CIR.0000149746.62908.BB15569841
  • Jia Q, Wang YR, He P, et al. Prediction model of in-hospital mortality in elderly patients with acute heart failure based on retrospective study. J Geriatr Cardiol. 2017;14(11):669–678. doi:10.11909/j.issn.1671-5411.2017.11.00229321797
  • Martin-Sanchez FJ. Comprehensive heart failure assessment: a challenge to modify the course of heart failure. Eur J Intern Med. 2020;71(71):8–10. doi:10.1016/j.ejim.2019.11.01331812537
  • Murphy L, Gray A, Joyce E. Anabolism to catabolism: serologic clues to nutritional status in heart failure. Curr Heart Fail Rep. 2019;16(5):189–200. doi:10.1007/s11897-019-00437-y31606846
  • Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–799. doi:10.1016/j.clnu.2008.06.01318718696
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi:10.1159/0001805801244564
  • Rubenstein LZ, Harker JO, Salva A, Guigoz Y, Vellas B. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol a Biol Sci Med Sci. 2001;56(6):M366–M372. doi:10.1093/gerona/56.6.M36611382797
  • DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845. doi:10.2307/25315953203132
  • Lassus J, Gayat E, Mueller C, et al. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol. 2013;168(3):2186–2194. doi:10.1016/j.ijcard.2013.01.22823538053
  • Ozcan M, Ozturk GZ, Kose M, et al. Evaluation of malnutrition with blood ghrelin and fecal elastase levels in acute decompensated heart failure patients. Turk Kardiyol Dern Ars. 2015;43(2):131–137. doi:10.5543/tkda.2015.0660625782117
  • Yang C, Liu Z, Liu K, Yang P. Mechanisms of Ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression. PLoS One. 2014;9(1):e85785. doi:10.1371/journal.pone.008578524465706
  • Lund LH, Williams JJ, Freda P, LaManca JJ, LeJemtel TH, Mancini DM. Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation. Eur J Heart Fail. 2009;11(8):789–794. doi:10.1093/eurjhf/hfp08819556330
  • Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 2001;104(17):2034–2038. doi:10.1161/hc4201.09783611673342
  • Mitacchione G, Powers JC, Grifoni G, et al. The gut hormone ghrelin partially reverses energy substrate metabolic alterations in the failing heart. Circ Heart Fail. 2014;7(4):643–651. doi:10.1161/CIRCHEARTFAILURE.114.00116724855152
  • Warbrick I, Rabkin SW. Effect of the peptides Relaxin, Neuregulin, Ghrelin and Glucagon-like peptide-1, on cardiomyocyte factors involved in the molecular mechanisms leading to diastolic dysfunction and/or heart failure with preserved ejection fraction. Peptides. 2019;111(111):33–41. doi:10.1016/j.peptides.2018.05.00929807087
  • Chen Y, Ji XW, Zhang AY, Lv JC, Zhang JG, Zhao CH. Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure. Arch Med Res. 2014;45(3):263–269. doi:10.1016/j.arcmed.2014.01.00424508287
  • Beiras-Fernandez A, Kreth S, Weis F, et al. Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure. Peptides. 2010;31(12):2222–2228. doi:10.1016/j.peptides.2010.08.01920804798
  • Aleksova A, Beltrami AP, Bevilacqua E, et al. Ghrelin derangements in idiopathic dilated cardiomyopathy: impact of myocardial disease duration and left ventricular ejection fraction. J Clin Med. 2019;8(8):8. doi:10.3390/jcm8081152
  • Itoh T, Nagaya N, Yoshikawa M, et al. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(8):879–882. doi:10.1164/rccm.200310-1404OC15271696
  • Du CK, Zhan DY, Morimoto S, et al. Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy. Pharmacol Res Perspect. 2014;2(5):e64. doi:10.1002/prp2.64
  • Nagaya N, Miyatake K, Uematsu M, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab. 2001;86(12):5854–5859. doi:10.1210/jcem.86.12.811511739451
  • Agra BR, Gonzalez FR, Varela RA, et al. Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure. Int J Cardiol. 2017;230(230):108–114. doi:10.1016/j.ijcard.2016.12.06728038805
  • Virdis A, Lerman LO, Regoli F, Ghiadoni L, Lerman A, Taddei S. Human ghrelin: a gastric hormone with cardiovascular properties. Curr Pharm Des. 2016;22(1):52–58. doi:10.2174/138161282266615111914445826581223
  • Pencina MJ, D’Agostino RS, D’Agostino RJ, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–172, 207–212. doi:10.1002/sim.2929
  • Attanasio P, Anker SD, Doehner W, von Haehling S. Hormonal consequences and prognosis of chronic heart failure. Curr Opin Endocrinol Diabetes Obes. 2011;18(3):224–230. doi:10.1097/MED.0b013e328346950521494135
  • Nishi I, Seo Y, Hamada-Harimura Y, et al. Utility of nutritional screening in predicting short-term prognosis of heart failure patients. Int Heart J. 2018;59(2):354–360. doi:10.1536/ihj.17-07329479009
  • Nishi I, Seo Y, Hamada-Harimura Y, et al. Nutritional screening based on the controlling nutritional status (CONUT) score at the time of admission is useful for long-term prognostic prediction in patients with heart failure requiring hospitalization. Heart Vessels. 2017;32(11):1337–1349. doi:10.1007/s00380-017-1001-828573538
  • Martin-Sanchez FJ, Cuesta TF, Rossello X, et al. Effect of risk of malnutrition on 30-day mortality among older patients with acute heart failure in emergency departments. Eur J Intern Med. 2019;65(65):69–77. doi:10.1016/j.ejim.2019.04.01431076345
  • Teixeira A, Arrigo M, Tolppanen H, et al. Management of acute heart failure in elderly patients. Arch Cardiovasc Dis. 2016;109(6–7):422–430. doi:10.1016/j.acvd.2016.02.00227185193